Russell Investments Group
ALNA

Russell Investments Group’s Allena Pharmaceuticals ALNA Stock Holding History

Russell Investments Group’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,093
Closed -$93K – 3054
2018
Q4 		$93K Buy
+17,093
New +$147K ﹤0.01% 2735

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Russell Investments Group's ALNA Position: Q1 2019 in Review

Russell Investments Group sold out of Allena Pharmaceuticals (ALNA) in Q1 2019, closing a stake of 17,093 shares — an estimated $93K sold.

Russell Investments Group first reported a position in ALNA in Q4 2018 and held it in 1 quarter. The position peaked at $93K in Q4 2018. 49 funds tracked by Wall St. Rank hold ALNA as of Q1 2019.

  • Russell Investments Group reported no remaining Allena Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Russell Investments Group sold 17,093 Allena Pharmaceuticals shares in Q1 2019, an estimated $93K.
  • Russell Investments Group first reported a position in Allena Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • Russell Investments Group's Allena Pharmaceuticals position peaked at $93K in Q4 2018.
  • 49 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2019.

Based on Russell Investments Group's 13F filing for Q1 2019, filed 13 May 2019.